Pathology
 |
|
2 april 2020 14:00:48 |
| H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells (Leukemia) |
|
Tweet |
| 161 viewsCategory: Pathology |
 Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways (Leukemia)Correction: Suprapubic pedicled phalloplasty in transgender men: a multicentric retrospective cohort analysis (International Journal of Impotence Research) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
